ProQR to host a conference call to discuss the top-line results of the Phase 2/3 Illuminate clinical trial of investigational RNA therapy sepofarsen in CEP20-mediated LCA10.
ARVO 2020 clinical trial results presentation by Stephen Russel et al. Sepofarsen had a manageable safety profile and showed improvement in mean visual acuity, and full-field stimulus testing.
… of Miami Miller School of Medicine. Dr. Lam is a clinical scientist with expertise and translational research … and ophthalmic epidemiology. In addition to clinical studies, his research focus includes gene therapy, … and biomarkers. Dr. Lam has participated in numerous clinical trials in hereditary retinal disease and …
